Keith S. Hansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keith S. Hansen has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Dor Yoeli
Division of Transplant Surgery, Department of Surgery Children's Hospital Colorado, University of Colorado Anschutz Medical Campus Aurora Colorado USA
3 shared publications James Cooper
Department of Medicine University of Colorado School of Medicine Aurora Colorado USA
3 shared publications- Kendra D. Conzen
Department of Surgery University of Colorado School of Medicine Aurora Colorado USA
3 shared publications - Megan A. Adams
Division of Transplant Surgery, Department of Surgery Children's Hospital Colorado, University of Colorado Anschutz Medical Campus Aurora Colorado USA
3 shared publications Peter Kennealey
Department of Surgery University of Colorado School of Medicine Aurora Colorado USA
3 shared publications- Phillipe Abreu
Department of Surgery Tufts Medical Center Boston Massachusetts USA
3 shared publications
Latest Publications
- 6 November 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11)
Pediatric Liver Transplantation Following Donation After Circulatory Death Using Normothermic Regional Perfusion: A Novel Application
Background: Normothermic regional perfusion (NRP) has transformed donation after circulatory death (DCD) liver transplantation (LT) in adult recipients, achieving outcomes comparable to donation after brain death (DBD). However, its application in pediatric LT remains underexplored. Methods: We report a case of a pediatric LT using a DCD liver graft recovered with thoracoabdominal NRP (TA‐NRP), performed in a 15‐year‐old female with fulminant hepatic failure secondary to acetaminophen overdose. The graft was recovered from a 45‐year‐old female donor. Case Description: Total donor warm ischemia, functional donor warm ischemia, and recipient warm ischemia were 65, 60, and 26 min, respectively. Cold ischemia time was 298 min, and TA‐NRP was performed for 130 min. After standard hepatectomy and piggyback implantation, the graft demonstrated immediate and sustained function, and the recipient was discharged from the surgical unit on postoperative day 23. At 18 months of follow‐up, graft function remains excellent with no graft‐related complications, episodes of rejection, or hospital readmissions. Conclusions: This case demonstrates the feasibility of pediatric LT using DCD‐NRP and supports further evaluation of NRP to expand the donor pool.
- 6 November 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11)
Pediatric Liver Transplantation Following Donation After Circulatory Death Using Normothermic Regional Perfusion: A Novel Application
Background: Normothermic regional perfusion (NRP) has transformed donation after circulatory death (DCD) liver transplantation (LT) in adult recipients, achieving outcomes comparable to donation after brain death (DBD). However, its application in pediatric LT remains underexplored. Methods: We report a case of a pediatric LT using a DCD liver graft recovered with thoracoabdominal NRP (TA‐NRP), performed in a 15‐year‐old female with fulminant hepatic failure secondary to acetaminophen overdose. The graft was recovered from a 45‐year‐old female donor. Case Description: Total donor warm ischemia, functional donor warm ischemia, and recipient warm ischemia were 65, 60, and 26 min, respectively. Cold ischemia time was 298 min, and TA‐NRP was performed for 130 min. After standard hepatectomy and piggyback implantation, the graft demonstrated immediate and sustained function, and the recipient was discharged from the surgical unit on postoperative day 23. At 18 months of follow‐up, graft function remains excellent with no graft‐related complications, episodes of rejection, or hospital readmissions. Conclusions: This case demonstrates the feasibility of pediatric LT using DCD‐NRP and supports further evaluation of NRP to expand the donor pool.
- 12 October 2026
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 22 (5) , e70244
Less is More: Robotic Kidney Transplantation in Polycystic Kidney Disease Without Preemptive or Simultaneous Native Nephrectomy
Background: Autosomal dominant polycystic kidney disease (ADPKD) often prompts pre‐transplantation or simultaneous native nephrectomy. Methods: We reviewed adult patients with ADPKD who underwent RKT without native nephrectomy at one transplant centre. Native kidney volume (NKV) and estimated abdominopelvic cavity volume (EACV) were estimated using ellipsoid approximations from cross‐sectional imaging, and a Spatial Occupancy Ratio (SOR = combined NKV/EACV) was derived to quantify anatomical crowding. Results: Sixteen patients underwent RKT for ADPKD without preemptive native nephrectomy, with a median SOR of 24.7%. Median warm ischaemia and operative times were 37 and 267 minutes, respectively, with an estimated blood loss of 50 mL. Increasing SOR demonstrated a moderate but significant inverse correlation with graft volume ( r = −0.52, p = 0.038) and a weak positive correlation with operative time ( r = 0.07, p = 0.80). Conclusions: RKT without native nephrectomy appears feasible across a broad spectrum of anatomical abdominopelvic occupancy, supporting a selective rather than routine approach to nephrectomy.
- 12 October 2026
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 22 (5) , e70244
Less is More: Robotic Kidney Transplantation in Polycystic Kidney Disease Without Preemptive or Simultaneous Native Nephrectomy
Background: Autosomal dominant polycystic kidney disease (ADPKD) often prompts pre‐transplantation or simultaneous native nephrectomy. Methods: We reviewed adult patients with ADPKD who underwent RKT without native nephrectomy at one transplant centre. Native kidney volume (NKV) and estimated abdominopelvic cavity volume (EACV) were estimated using ellipsoid approximations from cross‐sectional imaging, and a Spatial Occupancy Ratio (SOR = combined NKV/EACV) was derived to quantify anatomical crowding. Results: Sixteen patients underwent RKT for ADPKD without preemptive native nephrectomy, with a median SOR of 24.7%. Median warm ischaemia and operative times were 37 and 267 minutes, respectively, with an estimated blood loss of 50 mL. Increasing SOR demonstrated a moderate but significant inverse correlation with graft volume ( r = −0.52, p = 0.038) and a weak positive correlation with operative time ( r = 0.07, p = 0.80). Conclusions: RKT without native nephrectomy appears feasible across a broad spectrum of anatomical abdominopelvic occupancy, supporting a selective rather than routine approach to nephrectomy.
- 19 September 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 262, 117245
Outcomes after robotic and open kidney transplant: A propensity score-matched analysis
- 19 September 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 262, 117245
Outcomes after robotic and open kidney transplant: A propensity score-matched analysis
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (10) , 2355-2362
Safety in Robotic Kidney Transplant for All-Comers
Key Points: Robotic kidney transplantation demonstrates equivalent perioperative safety across body mass index strata, including body mass index ≥40 kg/m 2 . High body mass index alone was not associated with higher surgical complexity, delayed graft function, or early graft loss. Robotic kidney transplant may expand equitable access to transplantation by mitigating traditional obesity-related surgical risks. Background: Obesity remains a common barrier to kidney transplantation, with many centers enforcing strict body mass index (BMI) cutoffs because of concerns regarding surgical complexity and postoperative complications. Robotic kidney transplantation (RKT) has emerged as a minimally invasive alternative that may mitigate obesity-associated surgical risks. However, outcomes across granular BMI subgroups, particularly among patients with morbid obesity (BMI ≥40 kg/m 2 ), remain incompletely characterized. Methods: We performed a retrospective cohort study of adult patients undergoing RKT at a single academic transplant center between November 2021 and September 2025. Patients were stratified by BMI into two primary cohorts (BMI 2 ) with a secondary subgroup analysis comparing those with BMI 30–40 versus ≥40 kg/m 2 . Demographic characteristics, intraoperative metrics, and 30-day postoperative outcomes were compared. Results: A total of 104 patients underwent RKT, with 26 patients with BMI 2 , 53 with BMI between 30 and 40 kg/m 2 , and 25 with BMI ≥40 kg/m 2 . No significant differences were observed between BMI P = 0.03). In subgroup analysis, patients with BMI ≥40 demonstrated comparable intraoperative parameters and postoperative complication rates to those with BMI 30–40, with no significant differences in graft or patient survival. Conclusions: RKT is associated with comparable perioperative outcomes across BMI categories, including among patients with morbid obesity. These findings challenge rigid BMI-based exclusion criteria and support a more individualized approach to transplant candidacy in the era of robotic surgery.
- 1 July 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (10) , 2355-2362
Open AccessSafety in Robotic Kidney Transplant for All-Comers
Key Points: Robotic kidney transplantation demonstrates equivalent perioperative safety across body mass index strata, including body mass index ≥40 kg/m 2 . High body mass index alone was not associated with higher surgical complexity, delayed graft function, or early graft loss. Robotic kidney transplant may expand equitable access to transplantation by mitigating traditional obesity-related surgical risks. Background: Obesity remains a common barrier to kidney transplantation, with many centers enforcing strict body mass index (BMI) cutoffs because of concerns regarding surgical complexity and postoperative complications. Robotic kidney transplantation (RKT) has emerged as a minimally invasive alternative that may mitigate obesity-associated surgical risks. However, outcomes across granular BMI subgroups, particularly among patients with morbid obesity (BMI ≥40 kg/m 2 ), remain incompletely characterized. Methods: We performed a retrospective cohort study of adult patients undergoing RKT at a single academic transplant center between November 2021 and September 2025. Patients were stratified by BMI into two primary cohorts (BMI 2 ) with a secondary subgroup analysis comparing those with BMI 30–40 versus ≥40 kg/m 2 . Demographic characteristics, intraoperative metrics, and 30-day postoperative outcomes were compared. Results: A total of 104 patients underwent RKT, with 26 patients with BMI 2 , 53 with BMI between 30 and 40 kg/m 2 , and 25 with BMI ≥40 kg/m 2 . No significant differences were observed between BMI P = 0.03). In subgroup analysis, patients with BMI ≥40 demonstrated comparable intraoperative parameters and postoperative complication rates to those with BMI 30–40, with no significant differences in graft or patient survival. Conclusions: RKT is associated with comparable perioperative outcomes across BMI categories, including among patients with morbid obesity. These findings challenge rigid BMI-based exclusion criteria and support a more individualized approach to transplant candidacy in the era of robotic surgery.
- 18 January 2025
- Published by Elsevier
- p. 439-447
Case Study #1: Diatiro
- 18 January 2025
- Published by Elsevier
- p. 55-65
Health Economic and Commercial Value
- 18 January 2025
- Published by Elsevier
Contributors
- Open Access
- 3 May 2024
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 18, 100327
The influence of osteoporosis on mechanical complications in lumbar fusion surgery: a systematic review
- 3 May 2024
- Published by Elsevier in North American Spine Society Journal (NASSJ)
- Vol. 18, 100327
Open AccessThe influence of osteoporosis on mechanical complications in lumbar fusion surgery: a systematic review
- 27 March 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 188 (3) , 739-747
Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors
Purpose To determine the positive predictive value (PPV) of magnetic resonance imaging (MRI)-guided breast biopsy stratified by body mass index (BMI). Secondary endpoints include evaluation of indications for breast MRI and identification of factors associated with malignant biopsy. Methods We retrospectively analyzed results of MRI-guided breast biopsies in a consecutive cohort of women at a single institution between 2014 and 2019. The PPV was compared between BMI subgroups and the overall group by the one-sample z-test. Factors associated with malignant biopsy were analyzed using multivariate regression analysis. Results Among 427 MRI-guided breast biopsies, the PPV was significantly higher in patients with a BMI ≥ 35 compared to BMI < 35 (38.6% versus 24.5%, p = 0.043). This remained true in the 180 biopsies from high-risk screening studies, but there was no difference in PPV by BMI in the 205 biopsies performed to evaluate extent of known disease. Among this cohort who underwent MRI-guided breast biopsy, the underlying indication for MRI was less likely to be high-risk screening in those with a higher BMI or Black or Hispanic race (p = 0.015 and p < 0.001, respectively). For high-risk screening studies, only BMI ≥ 35 was associated with malignant biopsies (OR 37.5, p = 0.003). For evaluation of extent of disease studies, only increased lesion size was a significant predictor of malignant result (OR 1.01, p = 0.04). Conclusions Among women who underwent MRI-guided breast biopsy, elevated BMI was associated with increased PPV and malignant biopsies. Patients with a higher BMI or Black or Hispanic race who had MRI-guided biopsy were less likely to be undergoing high-risk screening and more likely to have breast MRI to evaluate extent of known disease.
- 27 March 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 188 (3) , 739-747
Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors
Purpose To determine the positive predictive value (PPV) of magnetic resonance imaging (MRI)-guided breast biopsy stratified by body mass index (BMI). Secondary endpoints include evaluation of indications for breast MRI and identification of factors associated with malignant biopsy. Methods We retrospectively analyzed results of MRI-guided breast biopsies in a consecutive cohort of women at a single institution between 2014 and 2019. The PPV was compared between BMI subgroups and the overall group by the one-sample z-test. Factors associated with malignant biopsy were analyzed using multivariate regression analysis. Results Among 427 MRI-guided breast biopsies, the PPV was significantly higher in patients with a BMI ≥ 35 compared to BMI < 35 (38.6% versus 24.5%, p = 0.043). This remained true in the 180 biopsies from high-risk screening studies, but there was no difference in PPV by BMI in the 205 biopsies performed to evaluate extent of known disease. Among this cohort who underwent MRI-guided breast biopsy, the underlying indication for MRI was less likely to be high-risk screening in those with a higher BMI or Black or Hispanic race (p = 0.015 and p < 0.001, respectively). For high-risk screening studies, only BMI ≥ 35 was associated with malignant biopsies (OR 37.5, p = 0.003). For evaluation of extent of disease studies, only increased lesion size was a significant predictor of malignant result (OR 1.01, p = 0.04). Conclusions Among women who underwent MRI-guided breast biopsy, elevated BMI was associated with increased PPV and malignant biopsies. Patients with a higher BMI or Black or Hispanic race who had MRI-guided biopsy were less likely to be undergoing high-risk screening and more likely to have breast MRI to evaluate extent of known disease.